UK regulators warn of ocular side effects after treatment
with Sanofi's Dupixent
After five years of Dupixent’s reign for Sanofi, the U.K.'s medicines regulatory agency is warning about risks of ocular side effects. The regulator asked patients and healthcare providers to look out for sudden changes in vision or eye pain after treatment. Patients are asked to “promptly report” new or worsening symptoms.
No comments:
Post a Comment